1. Introduction
1.1. Market Scope and Segmental Definition
1.2. Assumptions & Limitation
2. Research Methodology
2.1. Research Approach & Data Sources
2.2. Forecasting Model
3. Executive Summary
3.1. Top Line Market Estimation
3.2. Future Outlook
4. Market Overview
4.1. Industry Structure
4.2. Product classification
4.3. Value Chain Analysis
4.4. Player - Product Presence
4.5. Player - Segment Presence
4.6. Market Characteristics
4.7. Key Trends
4.8. Price Points
5. Market Forces
5.1. Key Industry Drivers, Restraints and Opportunities
5.2. Industry Trends
6. Market Outlook by Product (Current size & future market estimates)
6.1. Cough, Cold, and Flu Products
6.2. Analgesics
6.3. Dermatology Products
6.4. Gastrointestinal Products
6.5. Vitamins, Minerals, and Supplements (VMS)
6.6. Others
7. Market Outlook by Regions (Current size & future market estimates)
7.1. North
7.2. South
7.3. East
7.4. West
8. Competitive Landscape
8.1. Market Share/Market Ranking Analysis
8.2. Competitive Market Scenario (New Product Innovations, Key Strategic Moves & Partnerships, Start-ups Ecosystem)
9. Company Profiles Includes: Company Overview, Product & Services Offerings, Financials (only for listed companies), New Developments and Innovation)
9.1. GlaxoSmithKline PLC
9.2. Emami Limited
9.3. Abbott Laboratories
10. Companies covered for the analysis
10.1. Dabur India Limited
10.2. Procter & Gamble
10.3. Reckitt Benckiser
10.4. Sun Pharmaceuticals Limited
10.5. Cipla Inc.
10.6. Takeda Pharmaceutical Company
10.7. Boehringer Ingelheim
10.8. Pfizer Inc.
10.9. Takeda